General MedicineNMC Grounded

Status Epilepticus Resuscitation: AES Guidelines & Refractory Protocol

Harrison's Principles of Internal Medicine 21st Ed · Ch 427 Seizures & Epilepsy

$Status Epilepticus Resuscitation: AES Guidelines & Refractory Protocol anatomical & clinical diagram$

Verified Clinical DiagramHarrison's Principles of Internal Medicine 21st Ed · Ch 427 Seizures & Epilepsy

High-Yield Clinical Pearls & Exam Keys

Convulsive status epilepticus is an emergency defined as continuous seizure activity lasting > 5 minutes, or ≥ 2 discrete seizures between which there is incomplete recovery of consciousness.

Intramuscular Midazolam (10 mg for patients > 40 kg) is as effective as IV Lorazepam and is the preferred prehospital first-line treatment when intravenous access is not immediately established.

Fosphenytoin is a water-soluble prodrug of phenytoin that can be infused three times faster than phenytoin with significantly lower risk of cardiac arrhythmias and purple glove syndrome.

Ask Dr. Medarro about General Medicine

Instant NMC-grounded answers with standard textbook citations

AI Senior Mentor

Or tap a high-yield exam question:

Status Epilepticus Time Landmarks (ILAE Definition)

Key #1

Time t1 (5 Minutes): Seizure abnormally prolonged; initiate emergency first-line pharmacotherapy (Benzodiazepines)

Key #2

Time t2 (30 Minutes): Neuronal injury begins; risk of long-term pharmacoresistance and systemic complications skyrockets

Key #3

Refractory Status Epilepticus: Continued seizure activity despite adequate doses of a benzodiazepine AND a second-line antiepileptic

American Epilepsy Society (AES) Stepwise Treatment Algorithm

Phase & Time Window	First-Line Pharmacological Agent	Alternative Agent & Route
Phase 1: Initial (5 - 20 min)	IV Lorazepam 0.1 mg/kg (max 4 mg) OR IV Diazepam 0.15 mg/kg	IM Midazolam 10 mg (if no IV access) or Rectal Diazepam
Phase 2: Second-Line (20 - 40 min)	IV Levetiracetam (60 mg/kg, max 4500 mg) OR IV Fosphenytoin (20 mg PE/kg)	IV Sodium Valproate (40 mg/kg, max 3000 mg)
Phase 3: Refractory (> 40 min)	General anesthesia with continuous IV Propofol, Midazolam, or Ketamine	Continuous EEG monitoring targeting burst suppression pattern for 24-48 hours

Interactive Clinical Vignette Practice

Live Rule-Out Engine

Case Vignette #1NEET-PG Calibrated

A 32-year-old man with a known history of epilepsy is brought to the emergency department actively convulsing in generalized tonic-clonic status epilepticus for 12 minutes. No intravenous access has been established. What is the most appropriate first-line rescue medication according to current American Epilepsy Society guidelines?

AIntramuscular Midazolam (10 mg)

BSublingual Carbamazepine

CIntravenous Phenobarbital loading dose

DOral Levetiracetam via nasogastric tube

Comprehensive Clinical & Pathophysiological Breakdown

**1. Operational Definition ($t_1$ and $t_2$ Timepoints)** * **Generalized Convulsive Status Epilepticus (GCSE)**: - **$t_1$ (5 Minutes - Time to Initiate Treatment)**: Seizure duration beyond which spontaneous termination is unlikely and pharmacotherapy must be aggressively initiated to prevent permanent neuronal injury. - **$t_2$ (30 Minutes - Time of Irreversible Neuronal Damage)**: Duration beyond which seizure activity causes long-term neuronal apoptosis, pharmacoresistance (GABA receptor internalization and NMDA receptor upregulation), and systemic metabolic failure. **2. Phase I: Emergent Initial Therapy (0 to 5–10 Minutes)** * **Airway, Breathing, Circulation (ABC)**: High-flow oxygen via non-rebreather mask; establish IV access; bedside capillary blood glucose (if hypoglycemic: 50 mL of 50% Dextrose preceded by 100 mg IV Thiamine in adults to prevent Wernicke's encephalopathy). * **First-Line Benzodiazepines (Level A Evidence)**: 1. **IV Lorazepam**: **0.1 mg/kg IV** (usual adult dose: **4 mg IV** at 2 mg/min). Drug of choice when IV access is established due to lower lipid solubility and longer effective CNS retention (12–24h) compared to diazepam. May repeat once at 5–10 minutes. 2. **IM Midazolam**: **10 mg IM** (for weight >40 kg; 5 mg for 13–40 kg). **First-line treatment of choice when intravenous access is NOT yet established** (RAMPART trial proved non-inferiority/superiority of IM Midazolam over IV Lorazepam by paramedics). 3. **IV Diazepam**: 0.15–0.2 mg/kg (usual adult dose: 5–10 mg IV; repeat in 5 min if needed). Rapid brain entry but redistributes to fat within 20–30 minutes, risking seizure recurrence. 4. **Rectal Diazepam**: 0.2–0.5 mg/kg if IV/IM unavailable. **3. Phase II: Urgent Control Therapy (10 to 20–40 Minutes)** If seizures persist beyond 10 minutes despite adequate first-line benzodiazepine dosing, proceed immediately to Phase II (Established Status Epilepticus). *The ESETT (Established Status Epilepticus Treatment Trial) demonstrated equal efficacy (~50% seizure termination) across all three agents*: * **Option 1: IV Levetiracetam (Keppra)**: - Dose: **60 mg/kg IV** (maximum: 4,500 mg) infused over 10 minutes. - Advantages: No hepatic metabolism, minimal drug interactions, no cardiac monitoring required. * **Option 2: IV Fosphenytoin / Phenytoin**: - Dose: **20 mg PE/kg IV** (maximum: 1,500 mg PE). - Infusion Rate: Fosphenytoin up to 150 mg PE/min; Phenytoin max 50 mg/min (must dilute only in normal saline; requires continuous ECG and blood pressure monitoring due to propylene glycol vehicle causing **hypotension and cardiac arrhythmias**). * **Option 3: IV Sodium Valproate**: - Dose: **40 mg/kg IV** (maximum: 3,000 mg) infused over 5–10 minutes. Avoid in suspected mitochondrial disorders or liver failure. **4. Phase III: Refractory Status Epilepticus (RSE, >40–60 Minutes)** Seizures persisting despite adequate first-line benzodiazepine AND second-line non-sedating antiepileptic drug: * **MANDATORY**: Endotracheal intubation, mechanical ventilation, invasive arterial monitoring, and **Continuous Electroencephalography (cEEG)** in the Intensive Care Unit. * **Continuous IV Anesthetic Infusions (Titrated to Burst Suppression on EEG for 24–48 Hours)**: 1. *Midazolam*: 0.2 mg/kg IV loading bolus, followed by 0.05–2.0 mg/kg/h infusion. 2. *Propofol*: 1–2 mg/kg IV bolus, then 2–10 mg/kg/h. *Warning: Propofol Infusion Syndrome (PRIS)* with prolonged infusions >48h or >4–5 mg/kg/h (rhabdomyolysis, metabolic acidosis, hyperkalemia, cardiac arrest). 3. *Ketamine*: NMDA receptor antagonist (useful in late status when GABA receptors are internalized and NMDA receptors are upregulated). 4. *Thiopental / Pentobarbital*: Barbiturate coma reserved for ultra-refractory cases. **5. 📖 Standard Textbook Reference** * *Harrison's Principles of Internal Medicine*, 21st Ed., Ch. 445: Seizures and Epilepsy, pp. 3254–3270. * *Glauser T, et al*. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. *Epilepsy Currents*, 16(1):48–61.

Viva Examiner Traps & Model Answers

Oral Exam Prep

Why is the time threshold for initiating treatment in convulsive status epilepticus set at 5 minutes instead of the historical 30 minutes?

Physiological studies show that generalized tonic-clonic seizures rarely last longer than 2 to 3 minutes spontaneously. A seizure persisting beyond 5 minutes is unlikely to stop spontaneously and begins undergoing GABAA receptor internalization, making delay in treatment associated with pharmacoresistance and permanent hippocampal damage.

What is 'Purple Glove Syndrome', and how does Fosphenytoin prevent it?

Purple glove syndrome is an acute limb-threatening ischemic necrosis caused by extravasation of phenytoin formulated with propylene glycol (pH 12). Fosphenytoin is a water-soluble prodrug formulated at physiologic pH (8.6-9.0), eliminating vehicle-induced chemical phlebitis and purple glove necrosis.

What EEG endpoint is targeted when treating Super-Refractory Status Epilepticus?

Burst suppression with an interburst interval of 10 to 15 seconds, or complete electrographic seizure cessation, maintained for 24 to 48 hours before gradual anesthetic wean.

Additional Exam Practice Vignettes (1)

Case Vignette #2

A 45-year-old female in status epilepticus receives two doses of IV Lorazepam (4 mg each) without cessation of continuous tonic-clonic convulsions. It has now been 25 minutes since seizure onset. Which of the following second-line antiepileptic drugs is approved for rapid IV infusion as first-line non-benzodiazepine therapy?

In the ESETT trial, IV Levetiracetam (60 mg/kg, max 4500 mg), IV Fosphenytoin (20 mg PE/kg), and IV Sodium Valproate (40 mg/kg) were equally effective second-line therapies (Phase 2, 20-40 min).

Free Student Account Required

Unlock Complete Viva Traps & Additional Case Vignettes

Access model examiner answers, comprehensive rule-out breakdowns, and 4K spotter explanations.

Use email and password instead

Free student account•No credit card required

Medarro Study Hub

Want 50+ Clinical Vignettes & 4K 3D Spotters on General Medicine?

Practice Spaced Repetition Decathlon, generate instant 7-day adaptive study plans, and upload your college PDFs into the personal vault.

Related High-Yield Chapters

Surviving Sepsis Campaign Acute Coronary Syndrome Acid-Base Disorders